CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner

In this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection.

The sterile injectable drugs market is set to grow in the coming years, driven by the increasing use of injectables in the treatment of cancer, diabetes, and cardiovascular diseases, among others. The COVID-19 pandemic has also exacerbated demand and consequently, the market has seen a tightening of capacity.

For this reason, many biotech and pharma companies are now looking to outsource the manufacturing of their drug products, yet, many have limited-to-no experience of working with a CMO.

In this episode, our guest offers a step-by-step guide to help you understand at what point you need the support of a CMO, the key elements to include in your proposal, and the value you can expect to derive from your new partner.

Tune in now, and if you are looking to hear more from Baxter, why not register to our free webinar on 28 June - Common Stumbling Blocks When Outsourcing an Injectable Project to a CMO, and how to Avoid Them.